Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Garbayo

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|November 14, 2016
Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction modelSimon Pascual-Gil, Teresa Simón-Yarza, Elisa Garbayo, et al.
International Journal of Pharmaceutics|October 15, 2009
Production of highly pure human glycosylated GDNF in a mammalian cell lineEduardo Ansorena, Elisa Garbayo, José L Lanciego, et al.
Expert Opinion on Drug Delivery|October 14, 2022
Hydrogels for brain repair: application to Parkinson's diseaseRubén Del Campo-Montoya, María-Rosario Luquin, Elena Puerta, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2018
Micro- and nanotechnology approaches to improve Parkinson's disease therapyPablo Vicente Torres-Ortega, Laura Saludas, Amira Sayed Hanafy, et al.
Stem Cells Translational Medicine|May 1, 2015
Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's diseaseNicolas Daviaud, Elisa Garbayo, Laurence Sindji, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2021
Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative studyLaura Saludas, Elisa Garbayo, Adrián Ruiz-Villalba, et al.
Nanomaterials (Basel, Switzerland)|March 6, 2021
Extracellular Vesicle-Based Therapeutics for Heart RepairLaura Saludas, Cláudia C Oliveira, Carmen Roncal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2025
Squalene-adenosine nanoparticles enhance cardioprotection in myocardial infarction: Efficacy and mechanistic insightsLaura Saludas, Elisa Garbayo, Gloria Abizanda, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 15, 2022
Nanomedicines and cell-based therapies for embryonal tumors of the nervous systemSouhaila H El Moukhtari, Elisa Garbayo, Ana Fernández-Teijeiro, et al.
International Journal of Pharmaceutics|May 15, 2012
A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression systemEduardo Ansorena, Erkuden Casales, Alejandro Aranda, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|November 14, 2016
Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction modelSimon Pascual-Gil, Teresa Simón-Yarza, Elisa Garbayo, et al.
International Journal of Pharmaceutics|October 15, 2009
Production of highly pure human glycosylated GDNF in a mammalian cell lineEduardo Ansorena, Elisa Garbayo, José L Lanciego, et al.
Expert Opinion on Drug Delivery|October 14, 2022
Hydrogels for brain repair: application to Parkinson's diseaseRubén Del Campo-Montoya, María-Rosario Luquin, Elena Puerta, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2018
Micro- and nanotechnology approaches to improve Parkinson's disease therapyPablo Vicente Torres-Ortega, Laura Saludas, Amira Sayed Hanafy, et al.
Stem Cells Translational Medicine|May 1, 2015
Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's diseaseNicolas Daviaud, Elisa Garbayo, Laurence Sindji, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2021
Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative studyLaura Saludas, Elisa Garbayo, Adrián Ruiz-Villalba, et al.
Nanomaterials (Basel, Switzerland)|March 6, 2021
Extracellular Vesicle-Based Therapeutics for Heart RepairLaura Saludas, Cláudia C Oliveira, Carmen Roncal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2025
Squalene-adenosine nanoparticles enhance cardioprotection in myocardial infarction: Efficacy and mechanistic insightsLaura Saludas, Elisa Garbayo, Gloria Abizanda, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 15, 2022
Nanomedicines and cell-based therapies for embryonal tumors of the nervous systemSouhaila H El Moukhtari, Elisa Garbayo, Ana Fernández-Teijeiro, et al.
International Journal of Pharmaceutics|May 15, 2012
A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression systemEduardo Ansorena, Erkuden Casales, Alejandro Aranda, et al.
Pageof 5